All pharmacy types

Accountants for pharmacy buyers: due diligence, deal structure, and the tax decisions no broker will make for you.

When you buy a community pharmacy you are not buying a shop. You are buying an NHS contract, and market entry is regulated under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. The broker finds the deal; we do the work the broker cannot: financial due diligence on the contract income, the share-versus-asset structuring decision, goodwill tax treatment, and a set of accounts your lender will actually accept. Whether you are an existing owner adding a second store or a first-time buyer, the NHS-contract layer is where most acquirers get caught out.

0.5% vs up to 5%
Stamp duty on a share purchase (0.5% on share value) against SDLT at non-residential rates up to 5% on property in an asset purchase: the structuring decision is a real-money choice
£1,000,000
Annual Investment Allowance available at 100% on qualifying pharmacy fit-out plant and machinery, including dispensary robots, refrigeration, and shelving
40% FYA
First-year allowance introduced by FA 2026 for main-rate qualifying expenditure where AIA is exhausted, alongside a writing-down allowance now at 14% (down from 18%)

What makes buying a pharmacy accounting different.

The NHS contract is the asset, not the shop

Opening, relocating, or acquiring a pharmacy engages the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013. The NHS contract, the prescription volume it supports, and the NHSBSA payment history are what you are buying. GPhC-registered premises and the superintendent pharmacist requirements for company owners are the regulatory mechanics we cover on the ownership side. The financial due diligence must validate the contract, not just the till.

Share purchase or asset purchase: a structuring decision with tax consequences

An asset purchase attracts SDLT on any property at non-residential and mixed-use rates, which rise to 5% at the higher bands. A share purchase attracts 0.5% stamp duty on the shares but means you inherit the selling company's full history, including any historic tax exposures, pending HMRC enquiries, and employment liabilities. The right structure depends on the target's history, the property position, and your own tax position. We model both before you make an offer.

Goodwill dominates pharmacy pricing but CT relief is restricted

Pharmacy prices are driven by the NHS contract and item volume, and goodwill typically dominates the purchase price. On a company purchase, corporation tax relief on goodwill is restricted and available only in limited cases at fixed rates. That affects your real cost of acquisition and must be factored into affordability. Valuation stays method-level (adjusted EBITDA and pence-per-item approaches are the standard methods), and we never assert a specific multiple. See our <a href="/services/pharmacy-valuation-goodwill">pharmacy valuation and goodwill service</a> for the full picture.

Lender-ready accounts require NHS-adjusted maintainable earnings

A lender financing a pharmacy acquisition needs to see maintainable earnings adjusted for the FP34 cash-flow lag, Category M margin normalisation, and any one-off items in the historic accounts. Generic accountant-prepared accounts rarely make those adjustments explicitly. We prepare the financial analysis your lender needs and link it to the <a href="/calculators/pharmacy-purchase-affordability">purchase affordability calculator</a> for scenario modelling.

How we help buying a pharmacy.

Financial due diligence on the contract and the accounts

We verify FP34 income against NHSBSA payment statements, test Category M margin exposure, check the VAT retail-scheme position, and review payroll and staff costs for TUPE-relevant liabilities. This is the due-diligence layer the broker does not provide. See our <a href="/services/pharmacy-purchase-accounting">pharmacy purchase accounting service</a> for the full scope and use our <a href="/calculators/pharmacy-fp34-cash-flow-estimator">FP34 cash-flow estimator</a> to model the payment lag in the target business.

Share vs asset structure and goodwill treatment

We model the stamp-duty and SDLT cost of both structures, assess the CT relief position on goodwill for an asset purchase, and identify any history in the target company that makes shares more or less attractive. The output is a clear comparison you can put in front of your solicitor and your lender before heads of terms are agreed.

Capital allowances on the fit-out and ongoing accounting setup

Pharmacy fit-outs (shelving, dispensary robots, refrigeration, security systems) qualify as plant and machinery. The Annual Investment Allowance gives 100% relief on up to £1,000,000 of qualifying expenditure in the year of spend. Where AIA is exhausted, FA 2026 introduced a 40% first-year allowance for main-rate qualifying expenditure and reduced the writing-down allowance to 14% (from 18%); the special-rate pool stays at 6%. Qualifying works to the building itself attract the Structures and Buildings Allowance at 3% straight line. We claim the right allowances from day one of ownership.

Common questions

Am I buying the pharmacy or the NHS contract?
Effectively the NHS contract. The contract, the prescription volume it supports, and the NHSBSA payment stream are what give the business its value. Market entry and ownership changes engage the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013, and GPhC premises registration must be updated on a change of ownership. The financial due diligence must validate contract income, not just the retail till.
Should I buy the shares or the assets?
An asset purchase attracts SDLT on property at non-residential rates up to 5%. A share purchase attracts 0.5% stamp duty on the shares but means you inherit the selling company's history. The right answer depends on the property position, the target company's historic tax exposure, and how goodwill CT relief plays out in each structure. We model both before you commit.
Why is so much of the price goodwill, and can I get tax relief on it?
Pharmacy goodwill is driven by the NHS contract and item volume. It typically dominates the purchase price because the contract itself is what generates the income stream. On a company acquisition, CT relief on purchased goodwill is restricted and only available in limited cases. That restricted relief position affects the real after-tax cost of the deal and must be assessed deal-by-deal.
What should due diligence on a pharmacy actually check?
At minimum: FP34 NHSBSA payment history versus recorded income, Category M margin exposure and any pending clawbacks, VAT retail-scheme correctness, staff contracts and TUPE position, GPhC registration status, and any outstanding HMRC enquiries or historic tax exposures in the company. We provide pharmacy-specific financial due diligence that covers all of these.
Can I claim capital allowances on the fit-out?
Yes. Dispensary equipment, robots, refrigeration, shelving, and security systems are plant and machinery. The Annual Investment Allowance covers up to £1,000,000 at 100% in the year of spend. Where AIA is exhausted, FA 2026 introduced a 40% first-year allowance for main-rate qualifying expenditure, and the main-rate writing-down allowance is now 14% (down from 18%). Works to the building structure itself qualify for the Structures and Buildings Allowance at 3% straight line.
I am a locum pharmacist, can I buy my first pharmacy?
Yes, and the transition from locum to owner is a well-travelled route in the sector. The financial profile changes substantially: you move from Self Assessment on day-rate income to managing NHS contract cash flow, FP34 reconciliation, VAT retail schemes, and an employer payroll. Our <a href="/for/locum-pharmacists">locum pharmacists page</a> covers your current tax position, and we can walk you through what owning the contract changes.

Speak to a pharmacy finance specialist.

Tell us about your buying a pharmacy situation and we will reply within 24 hours.

Step 1 of 2 · About you

Optional: a bit more detail (helps us prepare)